Muller AG Cleaning Solutions Appoints Dr Christian Heuer As New Managing Director - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Muller AG Cleaning Solutions Appoints Dr Christian Heuer As New Managing Director


The Müller Group, a supplier of packaging, product handling, and cleaning systems mainly for pharmaceutical production, announced that it has appointed Dr Christian Heuer as new chief operating officer of Müller AG Cleaning Solutions. Long-standing managing director, Ruedi Peterhans, will focus on marketing and sales.

Heuer will be responsible for further developing the Systems/Handling/Cleaning business unit for pharmaceutical, cosmetic and food industry. With a chemical engineering doctorate from the Technical University of Berlin, Heuer brings on board his long-term international experience in the pharmaceutical market, particularly in cleaning and sterilization technology. He was previously responsible for global sales and marketing at the Belimed Group.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here